Twenty States Blast Price-Fixing of Generic Drugs
HARTFORD, Conn. (CN) – Connecticut and 19 states have led the charge against pharmaceutical giants that they say conspired to fix the prices of two generic drugs.
Filed with a federal judge in Hartford, the Dec. 15 complaint says Heritage Pharmaceuticals, Mylan Pharmaceuticals, Teva Pharmaceuticals and three other drugmakers conspired to manipulate the prices for doxycycline hyclate delayed release, an antibiotic, and glyburide, an oral diabetes medication.
Both Teva and Mylan denied the allegations. “To date, we have not found any evidence of price fixing within Teva and so on the facts we vigorously deny any allegations of wrongdoing,” Teva spokeswoman Denise Bradley said. Mylan Pharmaceuticals issued a similar statement: “To date, we know of no evidence that Mylan participated in price-fixing.”
A day before the suit was filed, the United States brought criminals charges against the former CEO and president of Heritage, Jeffrey Glazer and Jason Malek, respectively. Heritage, which sued both men in New Jersey last month, said it’s been cooperating with the Department of Justice’s continuing investigation.
More: Twenty States Blast Price-Fixing of Generic Drugs – Courthouse News Service